Medmain Inc.｜Meet.jobs

Medmain is a medical technology startup founded in January 2018 operating in telepathology and AI-driven pathological image diagnosis.

Our team consists of specialists from medical, deep learning and web development fields. As well as those based in Japan, we have staff and advisors working remotely from all over the world. Our main product, PidPort, provides quick and accurate pathological image diagnoses using deep learning. It is currently under development and soon to be launched. So far, we have raised several hundred million yen from venture capitals in and out of Japan. Through our cutting-edge technology, we strive to provide higher quality pathology globally, ultimately improving patients' lives.

■PidPort can change the clinical practice and the people related to healthcare. What is PidPort?

Globally, there is a severe shortage of pathologists, doctors who specialize in visually analyzing samples from tissues of a patient under the microscope to diagnose diseases and cancers. The turnaround time to obtain diagnostic results can take weeks, which causes tremendous mental stress to the patients and diseases to worsen. With our AI-driven product, PidPort, pathologists can now obtain a pathologic diagnosis in approximately 30 seconds with a 98% diagnostic accuracy. Pathologists and advisors from all over the world are collaborating to develop our product. Our product demonstration will soon begin at both domestic and international university hospitals. Currently, we are expanding our operation and organization to prepare for the official launch of our product. In the future, we envision PidPort to become a leader in the pathology space for both developed and developing countries.

[Awards]
Live Sharks Tank '17 - First Prize Winner, San Francisco, U.S.A.
Latitude59 '18 - Estonia Awards, Estonia
NICT Entrepreneurs’ Challenge '18 - First Prize Winner (MIC Awards), Japan
NewsPicks "MAKEMONEY" '19 - First Prize Winner, Japan

References:

https://www.linkedin.com/company/14562395/admin/